Limenbio
1 known investors
Find your way into Limenbio
Sign up to see every warm intro you have to Limenbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Limenbio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Limenbio develops gas-based preservation technology (branded HIPPER) for keeping viable cell grafts, tissues, and organs — including red blood cells, skin grafts, and hearts — using a modified gas atmosphere. Its methods target biomedical and transplantation applications such as extended organ and cell preservation prior to transplant.
Founders & leadership
AP
Alexander Ponomarev
Investors · 1
Frequently asked questions
- What does Limenbio do?
- Limenbio develops gas-based preservation technology (branded HIPPER) for keeping viable cell grafts, tissues, and organs — including red blood cells, skin grafts, and hearts — using a modified gas atmosphere. Its methods target biomedical and transplantation applications such as extended organ and cell preservation prior to transplant.
- Who founded Limenbio?
- Limenbio was founded by Alexander Ponomarev.
- Who are Limenbio's investors?
- Limenbio's investors include Kama Flow.
